NASDAQ · Analyst Forecast

Indaptus Therapeutics, Inc. (INDP) Stock Forecast & Price Target

$3.29 NASDAQ: INDP Market Cap $372.57M

Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Indaptus Therapeutics, Inc. (INDP), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Indaptus Therapeutics, Inc., analysts forecast revenue rising from $25.00M in 2021 to $123.05M in 2029; the average estimate for 2029 earnings per share is $6.40; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2021$25.00M$25.00M$25.00M1
2025$0$0$01
2026$0$0$01
2027$0$0$01
2028$42.39M$42.39M$42.39M1
2029$123.05M$123.05M$123.05M1

Earnings per share forecast

YearLowAverageHighAnalysts
2021−$130.34−$130.34−$130.341
2025−$20.79−$20.79−$20.791
2026−$6.34−$6.34−$6.341
2027−$4.42−$4.42−$4.421
2028$0.79$0.79$0.791
2029$6.40$6.40$6.401

Indaptus Therapeutics, Inc. (INDP) forecast — frequently asked questions

What are analysts forecasting for Indaptus Therapeutics, Inc.'s earnings?

The average analyst estimate for Indaptus Therapeutics, Inc. (INDP) earnings per share in 2029 is 6.40, with individual estimates between 6.40 and 6.40.

How much revenue is Indaptus Therapeutics, Inc. expected to make?

Analysts forecast Indaptus Therapeutics, Inc. (INDP) revenue of $123.05M in 2029, based on 1 published estimates.

How many analysts cover INDP?

1 analyst contribute estimates for Indaptus Therapeutics, Inc. (INDP). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.